In a Wednesday morning email sent site-wide on behalf of Andrew Espejo, who is general manager of Catalent’s manufacturing facility in Bloomington, the pharmaceutical manufacturing company has announced a reduction of its Bloomington workforce by 400 jobs.
The email indicates that employees—which include full-time and temporary employees, mostly within the operations team—will be notified between Wednesday and Friday to “discuss the next steps, review available support, and address any questions the impacted employees may have.”
Wednesday’s email message states: “Those who are not contacted by Human Resources should report to work as scheduled.”
The message also says, “[W]e’re committed to operating in a transparent manner to ensure every employee impacted by these changes has the information and support they need, severance pay, benefits continuation, and outplacement assistance.”
The email states that “every colleague on this team has performed admirably,” and adds that the workforce reduction is in “no way a reflection of the quality of the work we’ve done.” Continue reading “Company email: Catalent’s Bloomington operation to cut 400 jobs”